Shanghai Chicmax Cosmetic Co., Ltd. logo

Shanghai Chicmax Cosmetic Co., Ltd.

2145.HK

HKSEConsumer DefensiveHousehold & Personal Products

Latest quote

HK$24.32

−HK$0.06 · -0.25%

Aug 24, 11:59 AM HKT

2145.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Shanghai Chicmax Cosmetic Co., Ltd. is a multifaceted beauty corporation based in China, specializing in the entire product lifecycle—from innovation and production to market distribution—for skincare, as well as maternity and infant care lines. The company provides an extensive array of cosmetic goods, including specialized serums, moisturizing lotions, hair cleansers, and facial treatments, alongside various other dermatological and trichological solutions. These offerings are presented through a broad spectrum of brands such as KANS, One Leaf, Baby Elephant, BIO-G, asnami, KYOCA, newpage, ARMIYO, and TAZU. Furthermore, the firm actively oversees its supply chain management operations. Established in 2003 and headquartered in Shanghai, People's Republic of China, the company underwent a rebranding in 2020, transitioning from its former identity as Shanghai Kaka Cosmetic Co., Ltd.

Industry
Household & Personal Products
Sector
Consumer Defensive
Headquarters
CN
CEO
Yixiong Lyu
Listed since
Dec 22, 2022
Employees
3,508

Market position

Day range

Current HK$24.32

52-week range

Current HK$24.32

Open
HK$24.58
Previous close
HK$24.38
Volume
512.5K
0.31× average
Average volume
1.68M
Average daily volume
Market cap
9.68B HKD
Beta
0.29
Market reference 1
50-day average
HK$28.2632
-13.95% below average
200-day average
HK$54.3772
-55.28% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
25.85B CNY
EV / EBITDA
21.45×
Earnings yield
4.24%
Free cash flow yield
2.65%

Profitability & efficiency

Return on equity
39.81%
Return on assets
22.19%
Return on invested capital
25.04%

Financial health

Current ratio
1.85×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends84%54%25%-5%Gross margin, FY2021: 65.23%Gross margin, FY2022: 63.53%Gross margin, FY2023: 71.41%Gross margin, FY2024: 75.22%Gross margin, FY2025: 76.27%Operating margin, FY2021: 9.64%Operating margin, FY2022: 2.34%Operating margin, FY2023: 10.31%Operating margin, FY2024: 10.21%Operating margin, FY2025: 11.77%Net margin, FY2021: 9.36%Net margin, FY2022: 5.50%Net margin, FY2023: 11.00%Net margin, FY2024: 11.50%Net margin, FY2025: 12.01%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 65.23%. Gross margin FY2022 63.53%. Gross margin FY2023 71.41%. Gross margin FY2024 75.22%. Gross margin FY2025 76.27%. Operating margin FY2021 9.64%. Operating margin FY2022 2.34%. Operating margin FY2023 10.31%. Operating margin FY2024 10.21%. Operating margin FY2025 11.77%. Net margin FY2021 9.36%. Net margin FY2022 5.50%. Net margin FY2023 11.00%. Net margin FY2024 11.50%. Net margin FY2025 12.01%.

Income trends

Revenue

9.18B CNY+35.12%

Operating income

1.08B CNY+55.76%

Net income

1.1B CNY+41.14%
Income trends across reported periods10.09B CNY6.44B CNY2.8B CNY−848.84M CNYRevenue, FY2021: 3.62B CNYRevenue, FY2022: 2.68B CNYRevenue, FY2023: 4.19B CNYRevenue, FY2024: 6.79B CNYRevenue, FY2025: 9.18B CNYOperating income, FY2021: 348.73M CNYOperating income, FY2022: 62.67M CNYOperating income, FY2023: 432.24M CNYOperating income, FY2024: 693.75M CNYOperating income, FY2025: 1.08B CNYNet income, FY2021: 338.89M CNYNet income, FY2022: 147.1M CNYNet income, FY2023: 461.1M CNYNet income, FY2024: 781.21M CNYNet income, FY2025: 1.1B CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 3.62B CNY. Revenue FY2022 2.68B CNY. Revenue FY2023 4.19B CNY. Revenue FY2024 6.79B CNY. Revenue FY2025 9.18B CNY. Operating income FY2021 348.73M CNY. Operating income FY2022 62.67M CNY. Operating income FY2023 432.24M CNY. Operating income FY2024 693.75M CNY. Operating income FY2025 1.08B CNY. Net income FY2021 338.89M CNY. Net income FY2022 147.1M CNY. Net income FY2023 461.1M CNY. Net income FY2024 781.21M CNY. Net income FY2025 1.1B CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue9.18B CNY6.79B CNY4.19B CNY2.68B CNY3.62B CNY
Cost of goods sold2.18B CNY1.68B CNY1.2B CNY975.7M CNY1.26B CNY
Gross profit7B CNY5.11B CNY2.99B CNY1.7B CNY2.36B CNY
Research and development224.7M CNY179.87M CNY125.81M CNY110.28M CNY104.75M CNY
Selling, general, and administrative5.69B CNY4.19B CNY2.45B CNY1.48B CNY1.83B CNY
Operating expenses5.92B CNY4.19B CNY2.56B CNY1.5B CNY1.86B CNY
Interest income4.57M CNY6.13M CNY9.37M CNY814K CNY460K CNY
Interest expense7.4M CNY6.07M CNY16.23M CNY20.47M CNY20.93M CNY
Depreciation and amortization135.94M CNY68.59M CNY100.6M CNY94.17M CNY61.76M CNY
Operating income1.08B CNY693.75M CNY432.24M CNY62.67M CNY348.73M CNY
Net income1.1B CNY781.21M CNY461.1M CNY147.1M CNY338.89M CNY

Company facts updated Aug 24, 2026.

2145.HK peers

ETFs holding 2145.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 2145.HK

research.disclaimer